Myriad Genetics
MYGN
#3882
Rank
€2.31 B
Marketcap
25,53 €
Share price
-0.63%
Change (1 day)
57.87%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2023 (TTM): -2,84 €

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -2,74 €. In 2022 the company made an earnings per share (EPS) of -1,25 € a decrease over its 2021 EPS that were of -0,33 €.

EPS history for Myriad Genetics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,84 €126.57%
2022-1,25 €275.68%
2021-0,33 €-87.99%
2020-2,78 €755.56%
2019-0,32 €-194.74%
20180,34 €-79.89%
20171,71 €112.36%
20160,80 €-35.97%
20151,25 €-7.33%
20141,35 €-37.24%
20132,16 €59.33%
20121,35 €20.97%
20111,12 €-10.79%
20101,25 €14.88%
20091,09 €12.04%
20080,97 €-454.1%
2007-0,28 €-42.45%
2006-0,48 €-8.62%
2005-0,52 €-18.88%
2004-0,65 €22.22%
2003-0,53 €25.81%
2002-0,42 €200%
2001-0,14 €-13.89%
2000-0,16 €-15.27%
1999-0,19 €-24.79%
1998-0,25 €61.33%
1997-0,16 €-34.21%
1996-0,24 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-5,16 € 88.16%🇺🇸 USA
-1,43 €-47.84%🇺🇸 USA
-45,93 € 1,574.34%🇺🇸 USA
0,70 €-125.61%🇺🇸 USA
2,68 €-197.77%🇺🇸 USA